N⁶-methyladenosine as a Novel Regulator of Brain Physiology and Diseases

Abstract

N⁶-methyladenosine (m⁶A) is identified as the most widespread and abundant internal chemical modification of RNA in eukaryotes. A series of proteins including methyltransferases (also known as “writers”), demethylases (also known as “erasers”), and m⁶A-binding proteins (also known as “readers”) were indicated to participate in the m⁶A methylation. m⁶A has emerged as a regulator of various cellular, developmental, and disease processes. Notably, there is highest abundance of m⁶A methylation in brain than in other organs, which indicates that m⁶A plays an essential role in brain functions. Here, we describe the general features, mechanisms, and functions of m⁶A in the brain, and discuss the emerging roles of m⁶A in brain physiology and diseases.

Keywords

m⁶A / brain / physiology / diseases

References

[1] NgRK, GurdonJB. Epigenetic inheritance of cell differentiation status. Cell Cycle, 2008, 7(9): 1173-1177

[2] RoundtreeIA, EvansME, PanT. Dynamic RNA Modifications in Gene Expression Regulation. Cell, 2017, 169(7): 1187-1200

[3] AguiloF, WalshMJ. The N(6)-Methyladenosine RNA modification in pluripotency and reprogramming. Curr Opin Genet Dev, 2017, 46: 77-82

[4] GilbertWV, BellTA. Schaening C: Messenger RNA modifications: Form, distribution, and function. Science, 2016, 352(6292): 1408-1412

[5] WeiCM, MossB. Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acid. Biochemistry, 1977, 16(8): 1672-1676

[6] SchiblerU, KelleyDE, PerryRP. Comparison of methylated sequences in messenger RNA and heterogeneous nuclear RNA from mouse L cells. J Mol Biol, 1977, 115(4): 695-714

[7] BeemonK, KeithJ. Localization ofN6-methyladenosine in the Rous sarcoma virus genome. J Mol Biol, 1977, 113(1): 165-179

[8] RottmanFM, DesrosiersRC, FridericiK. Nucleotide methylation patterns in eukaryotic mRNA. Prog Nucleic Acid Res Mol Biol, 1976, 19: 21-38

[9] KrugRM, MorganMA, ShatkinAJ. Influenza viral mRNA contains internal N6-methyladenosine and 5′-terminal 7-methylguanosine in cap structures. J Virol, 1976, 20(1): 45-53

[10] FuY, DominissiniD, RechaviG, HeC. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat Rev Genet, 2014, 15(5): 293-306

[11] PatilDP, PickeringBF, JaffreySR. Reading m(6)A in the Transcriptome: m(6)A-Binding Proteins. Trends Cell Biol, 2018, 28(2): 113-127

[12] MeyerKD, JaffreySR. Rethinking m(6)A Readers, Writers, and Erasers. Annu Rev Cell Dev Biol, 2017, 33: 319-342

[13] ShiH, ZhangX, WengYL, et al.. m(6)A facilitates hippocampus-dependent learning and memory through YTHDF1. Nature, 2018, 563(7730): 249-253

[14] WangCX, CuiGS, LiuX, et al.. METTL3-mediated m6A modification is required for cerebellar development. PLoS Biol, 2018, 16(6): e2004880

[15] ChenM, WongCM. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Mol Cancer, 2020, 19(1): 44

[16] ChenRX, ChenX, XiaLP, et al.. N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun, 2019, 10(1): 4695

[17] BerulavaT, BuchholzE, ElerdashviliV, et al.. Changes in m6A RNA methylation contribute to heart failure progression by modulating translation. Eur J Heart Fail, 2020, 22(1): 54-66

[18] MathiyalaganP, AdamiakM, MayourianJ, et al.. FTO-Dependent N(6)-Methyladenosine Regulates Cardiac Function During Remodeling and Repair. Circulation, 2019, 139(4): 518-532

[19] ZhouP, WuM, YeC, et al.. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m(6)A abrogation in RNA. J Biol Chem, 2019, 294(45): 16908-16917

[20] XuY, YuanXD, WuJJ, et al.. The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1. J Cell Biochem, 2020, 121(1): 524-533

[21] MeyerKD, SaletoreY, ZumboP, et al.. Comprehensive analysis of mRNA methylation reveals enrichment in 3′UTRs and near stop codons. Cell, 2012, 149(7): 1635-1646

[22] SunT, WuR, MingL. The role of m6A RNA methylation in cancer. Biomed Pharmacother, 2019, 112: 108613

[23] WangX, FengJ, XueY, et al.. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature, 2016, 534(7608): 575-578

[24] WangP, DoxtaderKA, NamY. Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell, 2016, 63(2): 306-317

[25] SledzP, JinekM. Structural insights into the molecular mechanism of the m(6)A writer complex. Elife, 2016, 5: e18434

[26] LiuJ, YueY, HanD, et al.. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol, 2014, 10(2): 93-95

[27] PingXL, SunBF, WangL, et al.. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res, 2014, 24(2): 177-189

[28] PendletonKE, ChenB, LiuK, et al.. The U6 snRNA m(6)A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention. Cell, 2017, 169(5): 824-835

[29] SchwartzS, MumbachMR, JovanovicM, et al.. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5′ sites. Cell Rep, 2014, 8(1): 284-296

[30] PatilDP, ChenCK, PickeringBF, et al.. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature, 2016, 537(7620): 369-373

[31] WenJ, LvR, MaH, et al.. Zc3h13 Regulates Nuclear RNA m(6)A Methylation and Mouse Embryonic Stem Cell Self-Renewal. Mol Cell, 2018, 69(6): 1028-1038

[32] YueY, LiuJ, CuiX, et al.. VIRMA mediates preferential m(6)A mRNA methylation in 3′UTR and near stop codon and associates with alternative polyadenylation. Cell Discov, 2018, 4: 10

[33] van TranN, ErnstFGM, HawleyBR, et al.. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res, 2019, 47(15): 7719-7733

[34] MaH, WangX, CaiJ, et al.. N(6-)Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation. Nat Chem Biol, 2019, 15(1): 88-94

[35] YangY, HsuPJ, ChenYS, et al.. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res, 2018, 28(6): 616-624

[36] UedaY, OoshioI, FusamaeY, et al.. AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells. Sci Rep, 2017, 7: 42271

[37] WangL, WenM, CaoX. Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses. Science, 2019, 365(6454): eaav0758

[38] PengS, XiaoW, JuD, et al.. Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1. Sci Transl Med, 2019, 11(488): eaau7116

[39] ChenJ, FangX, ZhongP, et al.. N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction. RNA Biol, 2019, 16(8): 991-1000

[40] AlarconCR, GoodarziH, LeeH, et al.. HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events. Cell, 2015, 162(6): 1299-1308

[41] LiuN, DaiQ, ZhengG, et al.. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature, 2015, 518(7540): 560-564

[42] LiuN, ZhouKI, ParisienM, et al.. N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein. Nucleic Acids Res, 2017, 45(10): 6051-6063

[43] HuangH, WengH, SunW, et al.. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol, 2018, 20(3): 285-295

[44] HessME, HessS, MeyerKD, et al.. The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat Neurosci, 2013, 16(8): 1042-1048

[45] ChangM, LvH, ZhangW, et al.. Region-specific RNA m(6)A methylation represents a new layer of control in the gene regulatory network in the mouse brain. Open Biol, 2017, 7(9): 170166

[46] EngelM, EggertC, KaplickPM, et al.. The Role of m(6) A/m-RNA Methylation in Stress Response Regulation. Neuron, 2018, 99(2): 389-403

[47] MaC, ChangM, LvH, et al.. RNA m(6)A methylation participates in regulation of postnatal development of the mouse cerebellum. Genome Biol, 2018, 19(1): 68

[48] FryeM, HaradaBT, BehmM, et al.. RNA modifications modulate gene expression during development. Science, 2018, 361(6409): 1346-1349

[49] LiL, ZangL, ZhangF, et al.. Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis. Hum Mol Genet, 2017, 26(13): 2398-2411

[50] WengYL, WangX, AnR, et al.. Epitranscriptomic m(6)A Regulation of Axon Regeneration in the Adult Mammalian Nervous System. Neuron, 2018, 97(2): 313-325

[51] HoltCE, MartinKC, SchumanEM. Local translation in neurons: visualization and function. Nat Struct Mol Biol, 2019, 26(7): 557-566

[52] YuJ, ChenM, HuangH, et al.. Dynamic m6A modification regulates local translation of mRNA in axons. Nucleic Acids Res, 2018, 46(3): 1412-1423

[53] WidagdoJ, ZhaoQY, KempenMJ, et al.. Experience-Dependent Accumulation of N6-Methyladenosine in the Prefrontal Cortex Is Associated with Memory Processes in Mice. J Neurosci, 2016, 36(25): 6771-6777

[54] WaltersBJ, MercaldoV, GillonCJ, et al.. The Role of The RNA Demethylase FTO (Fat Mass and Obesity-Associated) and mRNA Methylation in Hippocampal Memory Formation. Neuropsychopharmacology, 2017, 42(7): 1502-1510

[55] ZhangZ, WangM, XieD, et al.. METTL3-mediated N(6)-methyladenosine mRNA modification enhances long-term memory consolidation. Cell Res, 2018, 28(11): 1050-1061

[56] ChaiRC, WuF, WangQX, et al.. m(6)ARNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas. Aging, 2019, 11(4): 1204-1225

[57] CuiQ, ShiH, YeP, et al.. m(6)A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells. Cell Rep, 2017, 18(11): 2622-2634

[58] VisvanathanA, PatilV, AroraA, et al.. Essential role of METTL3-mediated m(6)A modification in glioma stemlike cells maintenance and radioresistance. Oncogene, 2018, 37(4): 522-533

[59] ZhangS, ZhaoBS, ZhouA, et al.. m(6)A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell, 2017, 31(4): 591-606

[60] DuT, RaoS, WuL, et al.. An association study of the m6A genes with major depressive disorder in Chinese Han population. J Affect Disord, 2015, 183: 279-286

[61] MilaneschiY, LamersF, MbarekH, et al.. The effect of FTO rs9939609 on major depression differs across MDD subtypes. Mol Psychiatry, 2014, 19(9): 960-962

[62] SamaanZ, AnandSS, ZhangX, et al.. The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. Mol Psychiatry, 2013, 18(12): 1281-1286

[63] YaoY, WenY, DuT, et al.. Meta-analysis indicates that SNP rs9939609 within FTO is not associated with major depressive disorder (MDD) in Asian population. J Affect Disord, 2016, 193: 27-30

[64] DinaC, MeyreD, GallinaS, et al.. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet, 2007, 39(6): 724-726

[65] SunL, MaL, ZhangH, et al.. Fto Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice via Alterations in Gut Microbiota. Theranostics, 2019, 9(3): 721-733

[66] Huang R, Zhang Y, Bai Y, et al. N(6)-Methyladenosine Modification of Fatty Acid Amide Hydrolase Messenger RNA in Circular RNA STAG1-Regulated Astrocyte Dysfunction and Depressive-like Behaviors. Biol Psychiatry, 2020, doi: https://doi.org/10.1016/j.biopsych.2020.02.018

[67] ChokkallaAK, MehtaSL, KimT, et al.. Transient Focal Ischemia Significantly Alters the m(6)A Epitranscriptomic Tagging of RNAs in the Brain. Stroke, 2019, 50(10): 2912-2921

[68] LaneCA, HardyJ, SchottJM. Alzheimer’s disease. Eur J Neurol, 2018, 25(1): 59-70

[69] BatemanRJ, XiongC, BenzingerTL, et al.. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med, 2012, 367(9): 795-804

[70] HanM, LiuZ, XuY, et al.. Abnormality of m6A mRNA Methylation Is Involved in Alzheimer’s Disease. Front Neurosci, 2020, 14: 98

[71] LiH, RenY, MaoK, et al.. FTO is involved in Alzheimer’s disease by targeting TSC1-mTOR-Tau signaling. Biochem Biophys Res Commun, 2018, 498(1): 234-239

[72] ChenX, YuC, GuoM, et al.. Down-Regulation of m6A mRNA Methylation Is Involved in Dopaminergic Neuronal Death. ACS Chem Neurosci, 2019, 10(5): 2355-2363

[73] ZhouC, MolinieB, DaneshvarK, et al.. Genome-Wide Maps of m6A circRNAs Identify Widespread and Cell-Type-Specific Methylation Patterns that Are Distinct from mRNAs. Cell Rep, 2017, 20(9): 2262-2276

[74] YangY, FanX, MaoM, et al.. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res, 2017, 27(5): 626-641

[75] AlarconCR, LeeH, GoodarziH, et al.. N6-methyladenosine marks primary microRNAs for processing. Nature, 2015, 519(7544): 482-485